Cargando…

CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma

PURPOSE: Sorafenib is a multi-kinase inhibitor that is used as a standard treatment for advanced hepatocellular carcinoma (HCC). However, the mechanism of sorafenib resistance in HCC is still unclear. It has been shown that CISD2 expression is related to the progression and poor prognosis of HCC. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bowen, Wei, Shibo, Yang, Liang, Peng, Xueqiang, Ma, Yingbo, Wu, Bo, Fan, Qing, Yang, Shuo, Li, Xinyu, Jin, Hongyuan, Tang, Shilei, Huang, Mingyao, Li, Hangyu, Liu, Jingang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415543/ https://www.ncbi.nlm.nih.gov/pubmed/34485112 http://dx.doi.org/10.3389/fonc.2021.657723

Ejemplares similares

MicroRNA-375 Targets ATG14 to Inhibit Autophagy and Sensitize Hepatocellular Carcinoma Cells to Sorafenib
por: Yang, Shuo, et al.
Publicado: (2020)

LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation
por: Peng, Xueqiang, et al.
Publicado: (2021)

Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy
por: Huang, Mingyao, et al.
Publicado: (2020)

Rab GTPases: Central Coordinators of Membrane Trafficking in Cancer
por: Jin, Hongyuan, et al.
Publicado: (2021)

Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications
por: He, Guangpeng, et al.
Publicado: (2022)

Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma
por: Yang, Liang, et al.
Publicado: (2019)

The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders
por: Zhang, Sheng, et al.
Publicado: (2022)

Targeting tumor innervation: premises, promises, and challenges
por: Li, Xinyu, et al.
Publicado: (2022)

Mesenchymal/stromal stem cells: necessary factors in tumour progression
por: Li, Xinyu, et al.
Publicado: (2022)

miR-425 regulates lipophagy via SIRT1 to promote sorafenib resistance in liver cancer
por: Sun, Gongping, et al.
Publicado: (2021)

Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy
por: Zheng, Hongyu, et al.
Publicado: (2023)

CISD3 inhibition drives cystine-deprivation induced ferroptosis
por: Li, Yanchun, et al.
Publicado: (2021)

Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma
por: Li, Xiaoju, et al.
Publicado: (2022)

Cisd2 haploinsufficiency: A driving force for hepatocellular carcinoma
por: Shen, Zhao-Qing, et al.
Publicado: (2018)

Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies
por: Liu, Jiaxing, et al.
Publicado: (2022)

Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells
por: Fan, Qing, et al.
Publicado: (2018)

Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis
por: Liu, Qinqin, et al.
Publicado: (2021)

Modulation of Autophagy by Sorafenib: Effects on Treatment Response
por: Prieto-Domínguez, Nestor, et al.
Publicado: (2016)

A comprehensive review of the relationship between autophagy and sorafenib-resistance in hepatocellular carcinoma: ferroptosis is noteworthy
por: Zhang, Kangnan, et al.
Publicado: (2023)

Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial Dysfunction
por: Shao, Fangchun, et al.
Publicado: (2021)

The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
por: Hu, Xinyao, et al.
Publicado: (2021)

Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications
por: Li, Dai, et al.
Publicado: (2023)

Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma
por: Zheng, Jia, et al.
Publicado: (2022)

Effect of the Hypoxia Inducible Factor on Sorafenib Resistance of Hepatocellular Carcinoma
por: Zeng, Zhi, et al.
Publicado: (2021)

Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis
por: Li, Yan, et al.
Publicado: (2023)

Ferroptosis-associated gene CISD2 suppresses colon cancer development by regulating tumor immune microenvironment
por: Xu, Yuanyuan, et al.
Publicado: (2023)

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells
por: Li, Yue, et al.
Publicado: (2022)

ABHD12 contributes to tumorigenesis and sorafenib resistance by preventing ferroptosis in hepatocellular carcinoma
por: Cai, Mengxing, et al.
Publicado: (2023)

ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma
por: Huang, Wenbin, et al.
Publicado: (2021)

Focus on the morphogenesis, fate and the role in tumor progression of multivesicular bodies
por: Peng, Xueqiang, et al.
Publicado: (2020)

Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma
por: Zheng, Ruiqi, et al.
Publicado: (2023)

Efficacy and safety of lenvatinib versus sorafenib in first-line treatment of advanced hepatocellular carcinoma: A meta-analysis
por: Luo, Jia, et al.
Publicado: (2022)

Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3
por: Hu, Zongqiang, et al.
Publicado: (2023)

Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62–Keap1–NRF2 pathway
por: Li, Yanchun, et al.
Publicado: (2022)

MiR-127-3p targeting CISD1 regulates autophagy in hypoxic–ischemic cortex
por: Zhang, Zi-Bin, et al.
Publicado: (2021)

Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram
por: Zhang, Gong, et al.
Publicado: (2022)

Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis
por: Wen, Kai, et al.
Publicado: (2023)

Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis
por: Liu, Lixing, et al.
Publicado: (2020)

Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma
por: Li, Danyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_evmktt8k3i6vhrhc2d7v1phbpc